Galimand M, Lambert T, Gerbaud G, Courvalin P
Unité des Agents Antibactériens, Centre National de la Recherche Scientifique, Institut Pasteur, Paris, France.
Antimicrob Agents Chemother. 1993 Jul;37(7):1456-62. doi: 10.1128/AAC.37.7.1456.
Pseudomonas aeruginosa BM2656 was resistant to tobramycin and susceptible to gentamicin and amikacin by disk diffusion testing. This unusual resistance was not transferable by conjugation to Escherichia coli or P. aeruginosa PAO38, and plasmid DNA was not detected in this strain. A 0.9-kb fragment harboring the tobramycin resistance gene was cloned from BM2656 into pUC18, generating pAT129. Analysis for aminoglycoside-modifying activity in extracts of BM2656 and E. coli harboring pAT129 indicated that tobramycin resistance was due to synthesis of an aminoglycoside 6'-N-acetyltransferase type I [AAC(6')-I] enzyme which modified amikacin and tobramycin. Although amikacin was acetylated, the bactericidal synergism of this aminoglycoside with ceftazidime against BM2656 was minimally affected. The sequence of the DNA fragment was determined. It contained an aac (6')-Ib-like gene and was located downstream from a conserved region related to Tn21. The translated sequence of this aac(6')-Ib gene possessed 99.2% identity with the putative products of the aac(6')-Ib gene cassettes from Serratia marcescens and Klebsiella pneumoniae and 69% identity with the putative aacA(6')-II gene product from P. aeruginosa. We conclude that an aac(6')-Ib gene has spread to the chromosome of P. aeruginosa, probably by transposition.
通过纸片扩散试验,铜绿假单胞菌BM2656对妥布霉素耐药,而对庆大霉素和阿米卡星敏感。这种不寻常的耐药性不能通过接合转移至大肠杆菌或铜绿假单胞菌PAO38,并且在该菌株中未检测到质粒DNA。携带妥布霉素耐药基因的一个0.9 kb片段从BM2656克隆至pUC18,构建了pAT129。对携带pAT129的BM2656和大肠杆菌提取物中的氨基糖苷修饰活性进行分析表明,妥布霉素耐药是由于合成了一种I型氨基糖苷6'-N-乙酰转移酶[AAC(6')-I],该酶可修饰阿米卡星和妥布霉素。尽管阿米卡星被乙酰化,但该氨基糖苷与头孢他啶对BM2656的杀菌协同作用受到的影响最小。测定了该DNA片段的序列。它包含一个aac(6')-Ib样基因,位于与Tn21相关的保守区域下游。该aac(6')-Ib基因的翻译序列与粘质沙雷氏菌和肺炎克雷伯菌的aac(6')-Ib基因盒的推定产物具有99.2%的同一性,与铜绿假单胞菌的推定aacA(6')-II基因产物具有69%的同一性。我们得出结论,一个aac(6')-Ib基因可能通过转座扩散到了铜绿假单胞菌的染色体上。